$HCA

3 theses

bullish 0%neutral 0%bearish 100%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 10, 4:45 PM ET

$HCASEC Form 4bearish

Rossitto Erica · SVP & Chief Nurse Executive at HCA Healthcare, Inc. · 2h agono track record yet

Sold 3,500 @ $505.81 avg · $1,770,335 · 2026-11-10

Form 4: Rossitto Erica sold HCA

Rossitto Erica (SVP & Chief Nurse Executive at HCA Healthcare, Inc.) reported an open-market sale of 3,500 shares of HCA at an average $505.81, roughly $1,770,335, in a Form 4 filed 2026-11-10.

At post $504.42Now $504.420.0% since postedas of Nov 10, 4:45 PM ET

View filing on SEC.gov →

$HCASEC Form 4bearish

Schlosser Michael J · EVP and Chief Clinical Officer at HCA Healthcare, Inc. · 4d agono track record yet

Sold 1,200 @ $494.65 avg · $593,583 · 2026-11-04

Form 4: Schlosser Michael J sold HCA

Schlosser Michael J (EVP and Chief Clinical Officer at HCA Healthcare, Inc.) reported an open-market sale of 1,200 shares of HCA at an average $494.65, roughly $593,583, in a Form 4 filed 2026-11-06.

At post $494.99Now $504.42+1.9% since postedas of Nov 10, 4:45 PM ET

1d—

3d+2.0%

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$HCASEC Form 4bearish

Foster Jon M · EVP and COO at HCA Healthcare, Inc. · 4d agono track record yet

Sold 31,713 @ $500.98 avg · $15,887,482 · 2026-11-04

Form 4: Foster Jon M sold HCA

Foster Jon M (EVP and COO at HCA Healthcare, Inc.) reported an open-market sale of 31,713 shares of HCA at an average $500.98, roughly $15,887,482, in a Form 4 filed 2026-11-06.

At post $494.99Now $504.42+1.9% since postedas of Nov 10, 4:45 PM ET

1d—

3d+2.0%

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.